Cannabis Clinical Trials

BRIDGEWATER, N.J., Sept. 19, 2019 (GLOBE NEWSWIRE) — Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device, which uses its proprietary h-Patch™ technology, announced today data from its preclinical pharmacokinetic (PK) study of cannabidiol (CBD) subcutaneous infusion delivered via its h-Patch™ wearable drug delivery device have […]

by

Posted in: Medical Science News | Medical Research News | Medical Condition News Tags: Angelman Syndrome, Anxiety, Brain, Cannabidiol, Cannabis, Cell, Cell Biology, Clinical Trial, Disability, Efficacy, Epilepsy, Medicine, Neuroscience, Pain, Physiology, Preclinical, Research, Seizure, Sleep, Speech … read more at: https://www.news-medical.net/news/20190918/Cannabidiol-may-alleviate-seizures-and-normalize-brain-rhythms-in-Angelman-syndrome.aspx

by

Parkinson’s disease (PD) is a chronic neurological disorder that gets worse with time. There is no known cure for this disease, which causes a lack of control over bodily movements, depression, cognitive decline, and more.  This condition can be a very debilitating disorder, because it can affect eating, sleeping, and many other vital bodily functions […]

by

Zynerba Pharmaceuticals (NASDAQ: ZYNE) stock retreated on Wednesday after serious adverse events in phase 2 clinical trial of transdermal cannabidiol gel, Zygel. The shares were weak lately as the stock has fallen over 17% in the past month and over 31% in the past three months. Investors remained concerned about the company’s future and raised […]

by

TSX:IN OTCQX:IMLFF VANCOUVER, Sept. 19, 2019 /PRNewswire/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN;OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technology for the production of pharmaceutical-grade cannabinoids as well as a pipeline of medications targeting diseases with high unmet medical needs, today reported financial results for the three and twelve months […]

by

Phunware Inc (NASDAQ:PHUN) is launching an Initial Exchange Offering (IEO) for its own new currency called Phun tokens. The coin is designed to power the company’s Blockchain-Enabled Data Exchange and Mobile Loyalty Ecosystem which launched in June, allowing customers to unlock improved functionality and be rewarded for their engagement. Harvest One Cannabis Inc (CVE:HVT) (OTCMKTS:HRVOF) […]

by

Phunware Inc (NASDAQ:PHUN) is launching an Initial Exchange Offering (IEO) for its own new currency called Phun tokens. The coin is designed to power the company’s Blockchain-Enabled Data Exchange and Mobile Loyalty Ecosystem which launched in June, allowing customers to unlock improved functionality and be rewarded for their engagement. Harvest One Cannabis Inc (CVE:HVT) (OTCMKTS:HRVOF) […]

by

Security Devices International Inc (CSE:SDZ) (OTCMKTS:SDEV) revealed that the sales of its popular non-lethal personal security device Byrna HD fired up record preliminary sales for the third quarter. In a statement, the Wakefield, Massachusetts-based company said preliminary sales for the third quarter, which ended August 31, totaled $309,150, compared to $105,730 in the second quarter, […]

by

VANCOUVER, Sept. 19, 2019 /PRNewswire/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a biopharmaceutical company developing a proprietary biosynthesis manufacturing technology for the production of pharmaceutical-grade cannabinoids as well as a pipeline of medications targeting diseases with high unmet medical needs, today reported financial results for the three and twelve months ended […]

by

MONTREAL and SMITHS FALLS, ON, Sept. 16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Santé Cannabis, a pioneer in medical cannabis in Québec, has partnered with Spectrum Therapeutics, the medical division of Canopy Growth (TSX: WEED) […]

by

Non-profit educational and scientific society of physicians and health professionals, Society of Cannabis Clinicians (SCC) names Cannabis and Cannabinoid Research (CCR) its official journal. The decision to do so evidently stems from the fact that SSC is supportive of cannabis-related research and education for medicinal purposes. As per a press release by EurekAlert! the alliance […]

by

Seattle, Washington–(Newsfile Corp. – September 19, 2019) – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) and the massive growth potential in the European market. Image 1: XPhyto Therapeutics Corp. (www.xphyto.com) […]

by

HEXO Corp (HEXO) HEXO Corp is implementing a ‘hub and spoke’ strategy that aims to partner with established, Fortune 500 companies in five key sectors: cosmetics, health and wellness, edibles, vapes and beverages. Its first partner covers the beverage sector with beer giant Molson Coors, with HEXO owning 42.5% of the joint venture. It is […]

by

Kelowna, British Columbia–(Newsfile Corp. – September 18, 2019) – Allied Corp. (OTC Pink: ALID) (“Allied”), an international medical cannabis production company focused on creating and providing targeted cannabinoid health solutions, is pleased to announce its signing of a Letter Of Intent (“the LOI”) with Evoke Neurosciences (“Evoke”). Evoke’s eVox System generates an objective and automated […]

by